Form 4 for STAA STAAR SURGICAL CO
Accepted 2026-08-18 16:03:06 ET · period of report 2026-08-14 · accession 0001325697-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 16:03 | 2026-08-14 | STAA | ANDREWS DEBORAH J | CFO, EVP | M - OptEx | $0.00 | +5,233 | 41.5K | +14% | $0 |
| D | 2026-08-18 16:03 | 2026-08-14 | STAA | ANDREWS DEBORAH J | CFO, EVP | F - Tax | $26.18 | -2,662 | 38.9K | -6% | -$69.7K |
| DM | 2026-08-18 16:03 | 2026-08-14 | STAA | ANDREWS DEBORAH J | CFO, EVP | A - Grant | $0.00 | +43.1K | 29.2K | New | $0 |
| D | 2026-08-18 16:03 | 2026-08-14 | STAA | ANDREWS DEBORAH J | CFO, EVP | M - OptEx | $0.00 | +5,233 | 41.5K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | M | A | 5,233 | $0.00 | 41,452 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-14 | F | D | 2,662 | $26.18 | 38,910 | D | — | — | (F1) On May 15, 2026, the third tranche of 5,233 performance stock units ("PSUs") awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 2,662 shares were withheld to satisfy taxes. |
| 3 | Derivative | Restricted Stock Units | 2026-08-14 | A | A | 4,975 | $0.00 | 4,975 | D | $0.00 · — to — | 4,975 Common Stock | (F2) Each restricted stock unit ("RSU") represents the right to receive one share of STAAR Surgical Company ("Company") common stock upon vesting. (F3) The Reporting Person was granted Company RSUs on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. (F4) The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| 4 | Derivative | Stock Option (right to buy) | 2026-08-14 | A | A | 8,952 | $0.00 | 8,952 | D | $26.18 · — to 2036-08-13 | 8,952 Common Stock | (F5) The Reporting Person was granted an option to purchase 8,952 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installment thereafter. |
| 5 | Derivative | Performance Stock Option (right to buy) | 2026-08-14 | A | A | 29,159 | $0.00 | 29,159 | D | $26.18 · — to 2036-08-13 | 29,159 Common Stock | (F6) The Reporting Person was granted a performance option to purchase 29,159 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| 6 | Derivative | Performance Stock Units | 2026-08-14 | M | A | 5,233 | $0.00 | 41,452 | D | $0.00 · — to 2027-12-31 | 5,233 Common Stock | (F7) Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |